Clinical Trial Update: Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

AstraZeneca is conducting Phase 1/2 studies of AZD4512 as monotherapy or in combination with other anticancer agents in participants with B-cell acute lymphobla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• AZD4512

Snippet

Sponsor: AstraZeneca | Conditions: B-cell Acute Lymphoblastic Leukemia (B-ALL) | Phase 1, Phase 2 | Status: RECRUITING